Discuss the significance of Schedule K exemptions under the Drugs Rules, 1945, and examine recent government measures to curb their misuse.

Framed under the Drugs and Cosmetics Act, 1940, Schedule K of the Drugs Rules, 1945 exempts specified drug classes from licensing and other regulatory provisions [1]. It embodies a calibrated regulatory philosophy—balancing strict oversight against healthcare accessibility—but recent misuse of high-alcohol formulations has forced a rethink.

Significance of Schedule K exemptions

• Last-mile access: permitted retail of common formulations (tinctures of cardamom, ginger, cough syrups) without full licensing, aiding underserved rural areas [1].
• Ease of doing business: spared low-risk household remedies from disproportionate compliance costs.
• Federal balance: recognises States' role in regulating retail sale of everyday medicinal preparations [1].

The misuse problem

• Some exempted tinctures contained 80–90% v/v ethyl alcohol, enabling diversion for intoxication, a substance-abuse concern in vulnerable populations [1].

Recent government measures

• July 2026 amendment: formulations with >12% v/v alcohol in quantities exceeding 30 mL lose Schedule K exemption and shift to Schedule H1—sale only against a Registered Medical Practitioner's prescription with record-keeping [1].
• Precedent (G.S.R. 927(E), Dec 2025): removed "Syrup" from Schedule K, ending the cough-syrup exemption for villages under 1,000 population [2].
• Enforcement now rests with State drug controllers and licensed pharmacies, reflecting cooperative federalism [1].

These reforms mark a shift from reactive to precautionary regulation. Going forward, pairing tightened scheduling with rural pharmacy strengthening can uphold both public health and access—advancing SDG-3.